| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |